Bibliography （英文論文） 2002年

1. Terasaki-Fukuzawa Y, Kijima H, Suto A, Takeshita T, Iezumi K, Sato S, Yoshida H, Sato T, Shimbori M, Shiina Y. Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma. Int J Mol Med. 2002; 9: 25-29.
2. Tomii Y, Kamochi J, Yamazaki H, Sawa N, Tokunaga T, Ohnishi Y, Kijima H, Ueyama Y, Tamaoki N, Nakamura M. Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells. Int J Oncol. 2002; 20: 339-342.
3. Tanaka M, Kijima H, Itoh J, Matsuda T, Tanaka T. Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo. Cancer Gene Ther. 2002; 9: 483-488.
4. Uwatoko N, Tokunaga T, Hatanaka H, Osada H, Kawakami T, Yamazaki H, Abe Y, Kijima H, Ueyama Y, Nakamura M.Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma. Int J Oncol. 2002; 20: 729-733.
5. Tani M, Goto S, Kamada K, Mori K, Urata Y, Ihara Y, Kijima H, Ueyama Y, Shibata S, Kondo T. Hammerhead ribozyme against gamma-glutamylcysteine synthetase attenuates resistance to ionizing radiation and cisplatin in human T98G glioblastoma cells. Jpn J Cancer Res. 2002; 93: 716-722.
6. Kamochi J, Tokunaga T, Morino F, Nagata J, Tomii Y, Abe Y, Hatanaka H, Kijima H, Yamazaki H, Watanabe N, Matsuzaki S, Ueyama Y, Nakamura M. Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line. Int J Oncol 2002; 21:81-84.
7. Nagata J, Kijima H, Hatanaka H, Tokunaga T, Takagi A, Mine T, Yamazaki H, Nakamura M, Ueyama Y. Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med. 2002; 10: 169-172.
8. Nagata J, Kijima H, Hatanaka H, Tokunaga T, Kamochi J, Abe Y, Takagi A, Mine T, Yamazaki H, Nakamura M, Ueyama Y. Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med. 2002; 10: 423-426.
9. Nagata J, Kijima H, Hatanaka H, Asai S, Miyachi H, Abe Y, Yamazaki H, Nakamura M, Watanabe N, Mine T, Kondo T, Scanlon KJ, Ueyama Y. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene. Int J Oncol. 2002; 21: 1021-1026.
10. Tokunaga T, Abe Y, Tsuchida T, Hatanaka H, Oshika Y, Tomisawa M, Yoshimura M, Ohnishi Y, Kijima H, Yamazaki H, Ueyama Y, Nakamura M. Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line. Int J Oncol. 2002; 21:1027-1032.
11. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2002; 2: 289-300.
12. Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y, Osamura Y, Inoue H, Ueyama Y, Nakamura M. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer. 2002; 95: 2196-2201.
13. Matsubayashi H, Takagaki S, Otsubo T, Iiri T, Kobayashi Y, Yokota T, Shichijo K, Iwafuchi M, Kijima H. Pancreatic T-cell lymphoma with high level of soluble interleukin-2 receptor. J Gastroenterol. 2002; 37: 863-867.
14. Tobita K, Kijima H, Dowaki S, Oida Y, Kashiwagi H, Ishii M, Sugio Y, Sekka T, Ohtani Y, Tanaka M, Inokuchi S, Makuuchi H.　　Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. Int J Oncol. 2002; 21:1189-1195.
15. Tomii Y, Yamazaki H, Sawa N, Ohnishi Y, Kamochi J, Tokunaga T, Osamura Y, Sadahiro S, Kijima H, Abe Y, Ueyama Y, Tamaoki N, Nakamura M. Unique properties of 189 amino acid isoform of vascular endothelial growth factor in tumorigenesis. Int J Oncol. 2002; 21:1251-1257.